T3 Companies, LLC

Position in HROW — Harrow, Inc.

CIK 2052441 NEW YORK, NY

Position in HROW

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$212,350

-$140,250 QoQ

Shares Held

5,000

-50.0% QoQ

Ownership

0.013%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#158

of 221 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $7,960,424 across 5 Drug Manufacturers - Specialty & Generic names. HROW ranks #4 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	87,800	$7,000,294
2	NBIX	Neurocrine Biosciences Inc	2,000	$337,080
3	ESPR	Esperion Therapeutics, Inc.	82,500	$260,700
4	HROW	Harrow, Inc. This page	5,000	$212,350
5	BCRX	Biocryst Pharmaceuticals Inc	15,000	$150,000

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$212,350	5,000	-50.0%	Shares	Sole	2026-07-27
2026-03-31	$352,600	10,000	—	Shares	Sole	2026-05-07
No filing history on record for this holder in this stock.